The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.

Wang, Yong; Zheng, Jun; Zhu, Kongfu; Xu, Chengshi; Wang, Daping; Hou, Mengzhuo

Wang, Yong; Zheng, Jun; Zhu, Kongfu; Xu, Chengshi; Wang, Daping; Hou, Mengzhuo.

Wang Y; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, Mainz 55131, Germany.
Zheng J; Neurorehabilitation Department, Zhongnan Hospital of Wuhan University, China.
Zhu K; Department of Biomedical Engineering, Southern University of Science and Technology, China.
Xu C; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Wang D; Department of Biomedical Engineering, Southern University of Science and Technology, China.
Hou M; Department of Biomedical Engineering, Southern University of Science and Technology, China. Electronic address: jackson0086@163.com.

J Infect ; 2022 Aug 27.

Article in English | MEDLINE | ID: covidwho-2236856

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.08.021

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google